1,2,5,8-tetrahydroxy anthraquinone has been researched along with Breast Cancer in 2 studies
1,2,5,8-tetrahydroxy anthraquinone: structure in first source
quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zang, YQ | 1 |
| Feng, YY | 1 |
| Luo, YH | 1 |
| Zhai, YQ | 1 |
| Ju, XY | 1 |
| Feng, YC | 1 |
| Sheng, YN | 1 |
| Wang, JR | 1 |
| Yu, CQ | 1 |
| Jin, CH | 1 |
| Ilkar Erdagi, S | 1 |
| Ngwabebhoh, FA | 1 |
| Yildiz, U | 1 |
2 other studies available for 1,2,5,8-tetrahydroxy anthraquinone and Breast Cancer
| Article | Year |
|---|---|
Quinalizarin induces ROS‑mediated apoptosis via the MAPK, STAT3 and NF‑κB signaling pathways in human breast cancer cells.
Topics: Anthraquinones; Apoptosis; Breast Neoplasms; Extracellular Signal-Regulated MAP Kinases; Female; G2 | 2019 |
Pickering stabilized nanocellulose-alginate: A diosgenin-mediated delivery of quinalizarin as a potent cyto-inhibitor in human lung/breast cancer cell lines.
Topics: A549 Cells; Alginates; Anthraquinones; Breast Neoplasms; Cellulose; Diosgenin; Drug Delivery Systems | 2020 |